Can You Use the Extra Dose in the Mounjaro Pen?

You've just done your fourth injection and the pen still looks part-full

It's a moment most Mounjaro users notice eventually. You click through the fourth dose, cap the pen ready for disposal, and hold it up to the light. There is clearly something in there still. It looks like enough for another injection, maybe more. The instinct is understandable: this is an expensive medicine, and wasting anything feels wrong.

What you are seeing is a manufacturing overfill. Pharmaceutical pens (across many medicine types) are filled with slightly more liquid than the labelled doses require. This is not a secret extra dose left as a bonus; it is a quality-control measure. It ensures that even with small variations in the device's mechanics, every labelled dose is delivered accurately. Eli Lilly designed the KwikPen to deliver a precisely measured volume with each click, and the pen itself stops after the fourth delivery. The residual liquid has done its job by being there as a buffer. You can read a detailed breakdown of the pen's mechanics on our Mounjaro KwikPen extra dose page.

The NHS patient information for tirzepatide directs users to follow the instructions in the Patient Information Leaflet exactly. That leaflet specifies four doses per pen and does not describe any procedure for accessing remaining liquid.

Why trying to use the residual liquid is not the same as getting an extra dose

Some people wonder about drawing the remaining liquid into a separate syringe or pressing the plunger manually. There are several clear reasons not to.

First, the volume and concentration of what remains is not guaranteed to match a clinical dose. Overfill is not calibrated to be a fifth, usable injection. Second, the KwikPen needle is integrated and single-use. Attempting to manipulate the mechanism after it has auto-locked creates a risk of needlestick injury and introduces contamination risk. Third, and most practically: the pen is filled with a precise amount to deliver four doses at the labelled strength. You would have no reliable way of knowing what dose you were actually injecting.

There is also a licensing point. Mounjaro's UK marketing authorisation describes a specific regimen of once-weekly subcutaneous injection via the pre-filled KwikPen as directed. Using the pen outside those instructions places you outside the evidence base that established both the medicine's safety and its results. Our page on whether the Mounjaro extra dose can be used explores this in more detail.

If the cost of treatment is a factor in why this question matters to you, it is worth looking honestly at what is included in a full-service private prescription. Our Mounjaro price comparison page sets out what different providers typically include and where the gaps tend to be.

What to do if you feel your pen ran short, or if your dose needs reviewing

Occasionally people raise the reverse concern: the pen seemed to run out before the fourth dose, or a dose looked visibly smaller. If you believe a delivery was incomplete, the right step is to contact your prescriber or pharmacy the same day rather than repeat the injection. Double-dosing is not the answer, and a repeat injection on a hunch carries real risk of adverse effects.

Separately, if you are wondering about staying on your current dose for a further cycle rather than titrating up, that is a genuinely clinical question. Some people do well holding at a given strength for longer than the standard four weeks, particularly if they are still losing weight steadily or managing side effects. That conversation belongs with your prescriber. Our page on staying on the same Mounjaro dose outlines the factors clinicians typically weigh.

A question our prescribers hear fairly often is whether the last dose in the pen behaves differently from earlier ones. It does not. The fourth injection is identical in design to the first three; the pen mechanism does not degrade across use. If you want to explore this specifically, see our page on using the last dose of a Mounjaro pen.

Once you have finished with a pen, dispose of it safely in a sharps-aware way. The pen auto-locks after the final dose, which protects against accidental needlestick during disposal. Check your local council's sharps disposal guidance if you are unsure of the process, most areas have a collection scheme, and your pharmacist can advise.

When dose questions become prescriber questions

The broader point is this. Questions about what to do with your pen are questions about your prescription. The KwikPen is a delivery device; your regimen is a clinical plan. Trying to extract value from residual overfill is not a dosing decision, it is an improvisation outside the scope of your prescription, and no amount of visible liquid in the pen changes that.

If you feel your current dose is not working, if side effects are affecting your quality of life, or if you are wondering whether moving to a different strength sooner or later might help, those are exactly the conversations a prescriber is there for. Dose reviews at nume involve a real clinician reading your notes, not an automated system flagging a tick-box. It is worth booking one before the next pen arrives, especially if you are picking up the package before the school-run and want answers the same day rather than waiting for a callback.

The Mounjaro Summary of Product Characteristics on the eMC contains the full licensed prescribing information, including storage conditions and instructions for use. If you have specific questions about your treatment, speak to our prescribers, it is what they are there for.